Page 3 - ஜான்ஸ் ஹாப்கின்ஸ் பேவியூ மருத்துவ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA and CDC Recommend Pausing Johnson & Johnson COVID-19 Vaccine After Reported Blood Clots (Image: iStock.com/Mongkolchon Akesin) The Centers for Disease Control & Prevention and the Food and Drug AdministrationFederal have recommended pausing the use of Johnson & Johnson’s COVID-19 vaccine, after six reported U.S. cases of a rare and severe type of blood clot in individuals who received it. On April 13, the CDC and FDA issued a statement regarding the vaccine. “In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination,” the announcement said.

United statesJohns hopkins bayview medical centerCenters for disease control preventionAdvisory committee on immunization practicesMaryland department of healthMaryland department of health mdhealthdeptDisease controlDrug administrationfederalPolitical climate remainsAdvisory committeeImmunization practicesVaccine adverse event reporting systemEmergent biosolutionsJohns hopkins bayview medicalMaryland departmentஒன்றுபட்டது மாநிலங்களில்